Global Women’s Health Devices Market Growth (Status and Outlook) 2025-2031

The global Women’s Health Devices market size is predicted to grow from US$ 50130 million in 2025 to US$ 87800 million in 2031; it is expected to grow at a CAGR of 9.8% from 2025 to 2031.

Women’s health devices are specialized medical devices that can be any apparatus, instrument, or machine to be used for healthcare purposes, which are designed to monitor, diagnose, prevent, and cure several medical conditions without affecting the body. These devices are widely used in osteoporosis, hormone therapy, and pregnancy.

United States market for Women’s Health Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Women’s Health Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Women’s Health Devices is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Women’s Health Devices players cover Abbott, CALDERA MEDICAL, Carestream Health, Coloplast A/S, F. Hoffmann-La Roche Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Women’s Health Devices Industry Forecast” looks at past sales and reviews total world Women’s Health Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Women’s Health Devices sales for 2025 through 2031. With Women’s Health Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Women’s Health Devices industry.

This Insight Report provides a comprehensive analysis of the global Women’s Health Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Women’s Health Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Women’s Health Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Women’s Health Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Women’s Health Devices.

This report presents a comprehensive overview, market shares, and growth opportunities of Women’s Health Devices market by product type, application, key players and key regions and countries.

Segmentation by Type:
Diagnostics
Contraceptives
Surgical
Critical Care
Labor & Delivery
Others

Segmentation by Application:
Hospitals
Laboratories
Home Healthcare
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
CALDERA MEDICAL
Carestream Health
Coloplast A/S
F. Hoffmann-La Roche Ltd
GE HealthCare
Hologic, Inc.
Koninklijke Philips N.V.
MEDGYN PRODUCTS, INC.
Medline Industries, Inc.
Prestige Consumer Healthcare Inc.
Siemens

Please note: The report will take approximately 2 business days to prepare and deliver.